Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
Sponsor: Vanda Pharmaceuticals
Summary
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
Official title: An Eight-Week, Double-Masked, Randomized, Placebo-Controlled, Phase 2, Evaluation of the Safety and Efficacy of VSJ-110 Ophthalmic Solution in the Treatment of Dry Eye
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2025-10
Completion Date
2026-09
Last Updated
2025-09-17
Healthy Volunteers
No
Conditions
Interventions
VSJ-110
ophthalmic solution
Placebo
ophthalmic solution
Locations (5)
Vanda Investigational Site
Newport Beach, California, United States
Vanda Investigational Site
Andover, Massachusetts, United States
Vanda Investigational Site
Shelby, North Carolina, United States
Vanda Investigational Site
Memphis, Tennessee, United States
Vanda Investigational Site
Lynchburg, Virginia, United States